December 04, 2024

Which Obesity Drug Delivered 47% More Weight Loss?

Zepbound delivered 47% greater weight loss than Wegovy in a first-ever head-to-head trial, revealing its potential to reshape obesity treatment strategies.

Reuters

December 03, 2024

Dementia-Diabetes Link Stronger Than Expected

A review of sleep patterns in dementia patients found that 70-90% had at least one comorbidity, with sleep disturbances affecting treatment outcomes.

Conexiant

November 27, 2024

What are the Long-Term Outcomes in Anti-NMDAR Encephalitis?

Conexiant

November 27, 2024

Can Better AF Ablation Boost Success Rates?

Study unveils promising findings in the PROMPT-AF trial, where linear ablation with ethanol infusion via the vein of Marshall achieved 70.7% freedom from atrial arrhythmias at 12 months compared to 61.5% with pulmonary vein isolation alone.

Conexiant

November 27, 2024

High Prevalence of Psychiatric Comorbidities in Patients with Epilepsy

Conexiant

November 26, 2024

Lower eGDR Linked to Depression Risk

Conexiant

November 26, 2024

Cocoa Compounds Protect Arteries During Stress: Study

Conexiant

November 26, 2024

Postpartum Depression Doubles, Exposing Health Disparities

Conexiant

November 26, 2024

IDD Definitions Show 5-Fold Prevalence Variance

Conexiant